Report

Executive Summary: Evaluation of Cutaneous Leishmaniasis and Diabetes Mellitus Programs in Syria

Hasakeh Governorate, Al-Hol camp, hospital. Hamzah, 8, is being treated for internal foot erosion.
Diman Ameen/ICRC

This evaluation examines a health system strengthening programme implemented in partnership with Syria’s Ministry of Health (MoH), focusing on the treatment of Cutaneous Leishmaniasis (CL) and Diabetes Mellitus (DM). It assessed programme achievements and identified opportunities for sustainable knowledge transfer and handover to national authorities.

Findings indicate that sustainability considerations were incorporated into programme design, though their implementation varied across locations depending on service modality and operational conditions. Service delivery expanded significantly, with the number of treated CL and DM cases more than doubling since 2018. However, community feedback mechanisms remained largely informal.

The programme maintained relevance through adaptive design and coordination with national health authorities and partners. At the same time, monitoring systems could be further strengthened to better capture partnership contributions and longer-term health system strengthening effects. Further details are provided in the executive summary.

Download the Executive Summary Report in English and Arabic

25-079_Syria_Health_Assistance_ER_Executive_Summary_English.pdf
PDF file
280.38 KB
25-079_Syria_Health_Assistance_ER_Executive_Summary_Arabic.pdf
PDF file
277.23 كيلوبايت